Article
Public, Environmental & Occupational Health
Claudia Robles, Laia Bruni, Amelia Acera, Joan Carles Riera, Laia Prats, Mario Poljak, Jana Mlakar, Anja Ostrbenk Valencak, Tiina Eriksson, Matti Lehtinen, Karolina Louvanto, Maria Hortlund, Joakim Dillner, Mette T. Faber, Christian Munk, Susanne K. Kjaer, Karl Ulrich Petry, Agnieszka Denecke, Lan Xu, Marc Arbyn, Louise Cadman, Jack Cuzick, Veronique Dalstein, Christine Clavel, Silvia de Sanjose, F. Xavier Bosch
Summary: The study found that acceptance and completion of the human papillomavirus vaccination program in adult women largely depended on recruitment method, national vaccination program coverage, and personal relationship status. Knowledge of the benefits and safety of the vaccine may be crucial in expanding the target age for vaccination.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE
(2021)
Article
Oncology
Jacqueline M. Mix, Mona Saraiya, Trevor D. Thompson, Troy D. Querec, April Greek, Thomas C. Tucker, Edward S. Peters, Charles F. Lynch, Brenda Y. Hernandez, Glenn Copeland, Marc T. Goodman, Elizabeth R. Unger
Summary: The study compared HPV prevalence among high-grade cervical precancers and invasive cervical cancers before and after HPV vaccine availability. No significant reduction in vaccine-type prevalence was observed between the two studies, likely due to low HPV vaccination coverage among women in the postvaccine study. Monitoring HPV-type prevalence through population-based strategies remains important for evaluating the impact of the HPV vaccine.
Article
Public, Environmental & Occupational Health
Juman Rezqalla, Mariam Alshatti, Amna Ibraheem, Danah Omar, Al-Failakawi Houda, Shamayel AlHaqqan, Sarah AlGhurair, Saeed Akhtar
Summary: This study found high levels of unawareness among female schoolteachers regarding the causal role of HPV in cervical cancer and the availability of HPV vaccine. Participants who were younger and had lower family incomes were more likely to be unaware of HPV's role in cervical cancer. Additionally, participants with a family or personal history of cervical cancer were less likely to be unaware of HPV's causal role.
JOURNAL OF INFECTION AND PUBLIC HEALTH
(2021)
Article
Health Care Sciences & Services
Sunny Jung Kim, Jenna E. Schiffelbein, Inger Imset, Ardis L. Olson
Summary: This study found that evidence-based messages in social media can effectively change parents' attitudes and behavioral intentions towards HPV vaccination. Messages that provide scientific evidence and correct misinformation are particularly effective in promoting positive perceptions of the HPV vaccine.
JOURNAL OF MEDICAL INTERNET RESEARCH
(2022)
Article
Oncology
Brooke Cherven, James L. Klosky, Yanjun Chen, Jocelyn M. York, Karen Heaton, Gwendolyn Childs, Jessica S. Flynn, James A. Connelly, Karen Wasilewski-Masker, Leslie L. Robison, Melissa M. Hudson, F. Lennie Wong, Smita Bhatia, Wendy Landier
Summary: Young adult cancer survivors are at risk for HPV-related malignancies due to high-risk sexual behavior, but low rates of HPV vaccine initiation. Factors related to high-risk sexual behaviors can help reduce HPV acquisition risk among survivors.
JOURNAL OF CANCER SURVIVORSHIP
(2021)
Review
Oncology
Biyuan Xing, Jianfeng Guo, Yuhan Sheng, Gang Wu, Yingchao Zhao
Summary: HPV-negative cervical cancers, predominantly adenocarcinomas, pose challenges in diagnosis and management due to unclear etiology and possible false negative results. It is important to pay greater attention to these cases as they are often diagnosed at advanced stages with poor prognoses.
FRONTIERS IN ONCOLOGY
(2021)
Article
Medicine, General & Internal
Khalid Akkour, Lolowah Alghuson, Hicham Benabdelkamel, Hani Alhalal, Nada Alayed, Amal AlQarni, Maria Arafah
Summary: The survey highlighted a lack of awareness among Saudi women regarding HPV, its transmission, and the importance of vaccines. The internet was the main source of information, and only a small percentage of women had received the HPV vaccine. Organized campaigns and education programs are needed to improve awareness and promote vaccination.
MEDICINA-LITHUANIA
(2021)
Article
Immunology
Lauri E. Markowitz, John T. Schiller
Summary: HPV vaccines are highly effective in preventing HPV-attributable cancers and have been introduced into national immunization programs in over 100 countries. The success of these vaccines has sparked interest in ambitious disease reduction goals.
JOURNAL OF INFECTIOUS DISEASES
(2021)
Article
Immunology
Nchang'wa Nhumba, Bruno Sunguya
Summary: Cervical cancer is a major health issue in Tanzania, and the HPV vaccine is an effective intervention. However, the uptake of the second dose of the vaccine is low, with factors such as age, attitude, and awareness influencing the uptake.
Article
Immunology
Supitcha Kamolratanakul, Punnee Pitisuttithum
Summary: Human papillomavirus (HPV) is the most common sexually transmitted infection, with 15 HPV types related to various cancers. HPV vaccines have been proven to be safe and highly effective in preventing HPV infections and associated cancers, especially among young women. The different types of HPV vaccines have shown similar efficacy in protecting against certain HPV types, with the nonavalent vaccine offering additional protection against more types. HPV vaccination has also been shown to provide herd protection and reduce the prevalence of HPV-related cancers.
Article
Immunology
Howard D. Strickler, Marla J. Keller, Nancy A. Hessol, Isam-Eldin Eltoum, Mark H. Einstein, Philip E. Castle, L. Stewart Massad, Lisa Flowers, Lisa Rahangdale, Jessica M. Atrio, Catalina Ramirez, Howard Minkoff, Adaora A. Adimora, Igho Ofotokun, Christine Colie, Megan J. Huchko, Margaret Fischl, Rodney Wright, Gypsyamber D'Souza, Jason Leider, Olga Diaz, Lorraine Sanchez-Keeland, Sadeep Shrestha, Xianhong Xie, Xiaonan Xue, Kathryn Anastos, Joel M. Palefsky, Robert D. Burk
Summary: The study found that in women living with HIV, primary human papillomavirus screening (PHS) combined with reflex HPV16/18 genotyping can reduce unnecessary colposcopies, potentially serving as an alternative to co-testing.
CLINICAL INFECTIOUS DISEASES
(2021)
Article
Oncology
Brooke Cherven, James L. Klosky, K. Elizabeth Keith, Melissa M. Hudson, Smita Bhatia, Wendy Landier
Summary: Cancer survivors refuse HPV vaccine primarily due to concerns about safety, lack of interest, external influences, information deficits, and health beliefs/family decisional processes. Females are more likely to refuse based on health beliefs/family decisional processes, while males are more likely to do so because of external influences.
Article
Immunology
Mariko Taniguchi, Yutaka Ueda, Asami Yagi, Ai Miyoshi, Yusuke Tanaka, Ryoko Minekawa, Masayuki Endo, Takuji Tomimatsu, Kei Hirai, Tomio Nakayama, Tadashi Kimura
Summary: Women born between 1994 and 1999 with high HPV vaccination rates in Japan are now at the age for cervical cancer screening. Research showed that vaccinated women had better health awareness, while unvaccinated women were more influenced by fear of cancer. Tailored leaflets recommending screening increased rates slightly for both groups, indicating potential for improving cervical cancer control measures tailored to HPV vaccination status.
Article
Oncology
Tessa M. Schurink-van 't Klooster, Albert G. Siebers, Joske Hoes, Folkert J. van Kemenade, Johannes Berkhof, Johannes A. Bogaards, Hester E. de Melker
Summary: By linking national registries on vaccination and pathology, this study found significant beneficial early effects of HPV-vaccination on cytological abnormalities and high-risk HPV positivity in cervical samples of young women who have not yet entered the regular screening program.
Article
Virology
Neda Hosseini, Zabihollah Shoja, Sarang Younesi, Nazanin-Zahra Shafiei-Jandaghi, Somayeh Jalilvand
Summary: The study found that lineage A of HPV 31 was predominant in Iran, while lineage B of HPV 45 was also dominant among Iranian women. Further research with larger sample sizes is needed to evaluate the pathogenicity risk of HPV 31 or HPV 45 lineages/sublineages in the development of cervical cancer among Iranian women.
JOURNAL OF MEDICAL VIROLOGY
(2021)